1.
Śwituła M. Ranibizumab for wet AMD – several years own observations of patients with preserved good visual acuity despite of extensive subretinal neovascularization. Ophthatherapy [Internet]. 2015Mar.31 [cited 2024Nov.22];2(1):48-5. Available from: https://journalsmededu.pl/index.php/ophthatherapy/article/view/616